Long-term follow up of selinexor maintenance in patients with TP53 wt advanced or recurrent endometrial cancer: A pre-specified subgroup analysis from the phase 3 ENGOT-EN5/GOG-3055/SIENDO study Meeting Abstract


Authors: Slomovitz, B. M.; Perez-Fidalgo, J. A.; Hamilton, E. P.; Valabrega, G.; Van Gorp, T.; Sehouli, J.; Klat, J.; Levy, T.; Welch, S.; Richardson, D. L.; Guerra Alia, E. M.; Scambia, G.; Henry, S.; Wimberger, P.; Martinez, J.; Monk, B. J.; Kalyanapu, P.; Raza Mirza, M; Makker, V.; Vergote, I.
Abstract Title: Long-term follow up of selinexor maintenance in patients with TP53 wt advanced or recurrent endometrial cancer: A pre-specified subgroup analysis from the phase 3 ENGOT-EN5/GOG-3055/SIENDO study
Meeting Title: 2023 ASCO Monthly Plenary Series
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 36 Suppl.
Meeting Dates: 2023 Jul 25
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-12-10
Language: English
DOI: 10.1200/JCO.2023.41.36_suppl.427956
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting abstract: 427956 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vicky Makker
    263 Makker